Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The receptor binding domain of SARS-CoV-2 spike is the key target of neutralizing antibody in human polyclonal sera
Tara L. Steffen, E. Taylor Stone, Mariah Hassert, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 463-476.e6
Open Access | Times Cited: 1230
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, et al.
Cell Host & Microbe (2020) Vol. 29, Iss. 1, pp. 44-57.e9
Open Access | Times Cited: 1077
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
Science (2021) Vol. 372, Iss. 6549, pp. 1413-1418
Open Access | Times Cited: 581
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
Allison J. Greaney, Tyler N. Starr, Christopher O. Barnes, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 408
Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies
Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 199
Learning from the past: development of safe and effective COVID-19 vaccines
Shan Su, Lanying Du, Shibo Jiang
Nature Reviews Microbiology (2020) Vol. 19, Iss. 3, pp. 211-219
Open Access | Times Cited: 164
Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
Daniele Focosi, Fabrizio Maggi
Reviews in Medical Virology (2021) Vol. 31, Iss. 6
Open Access | Times Cited: 162
Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination
Sarah Cobey, Daniel B. Larremore, Yonatan H. Grad, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 5, pp. 330-335
Open Access | Times Cited: 124
Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis
Angel Yun-Kuan Thye, Jodi Woan‐Fei Law, Priyia Pusparajah, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1303-1303
Open Access | Times Cited: 122
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area
S. Wesley Long, Randall J. Olsen, Paul A. Christensen, et al.
mBio (2020) Vol. 11, Iss. 6
Open Access | Times Cited: 138
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition
Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 136
A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 98
E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies
Wei Bu Wang, Yu Liang, Yu Jin, et al.
Journal of Molecular Graphics and Modelling (2021) Vol. 109, pp. 108035-108035
Open Access | Times Cited: 70
Viral infection neutralization tests: A focus on severe acute respiratory syndrome‐coronavirus‐2 with implications for convalescent plasma therapy
Daniele Focosi, Fabrizio Maggi, Paola Mazzetti, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 2
Open Access | Times Cited: 59
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies
Allison J. Greaney, Tyler N. Starr, Christopher O. Barnes, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 48
Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
Liyana Ahmad
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45
Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2
Ariana Ghez Farrell, Bernadeta Dadonaite, Allison J. Greaney, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 2061-2061
Open Access | Times Cited: 31
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area
S. Wesley Long, Randall J. Olsen, Paul A. Christensen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 41
Function Is More Reliable than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination
Carlos A. Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, et al.
Viruses (2021) Vol. 13, Iss. 10, pp. 1972-1972
Open Access | Times Cited: 33
State of the Art in Epitope Mapping and Opportunities in COVID-19
Samira M. Hamed, Masarra M. Sakr, Ghadir S. El-Housseiny, et al.
Future Science OA (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 13
mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2
Mariah Hassert, Elizabeth Geerling, E. Taylor Stone, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 12, pp. e1009163-e1009163
Open Access | Times Cited: 29
E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies
Wei Bu Wang, Yu Liang, Yu Jin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 26
Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases
Tharmala Tharmalingam, Xiaobing Han, Ashley Wozniak, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 18, Iss. 2
Open Access | Times Cited: 24
Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants
Indrani Das Jana, Kawkab Kanjo, Subhanita Roy, et al.
Journal of Virology (2025)
Open Access
A novel consensus‐based computational pipeline for screening of antibody therapeutics for efficacy against SARS‐CoV‐2 variants of concern including Omicron variant
Naveen Kumar, Rahul Kaushik, Kam Y. J. Zhang, et al.
Proteins Structure Function and Bioinformatics (2023) Vol. 91, Iss. 6, pp. 798-806
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top